Pfizer To Cooperate With Peking University Health Science Center In Quantitative Pharmacology Education
This article was originally published in PharmAsia News
Pfizer China and Peking University Health Science Center will jointly establish Peking University - Pfizer quantitative pharmacology education center. According to the long-term agreement, Pfizer will set aside RMB 3 million to fund education and training of Chinese scientific talent in quantitative pharmacology, a critical technology in pharmaceutical R&D. Peking University expresses that the new center will help strengthen its capability in the domain. (Click here for more - Chinese Language)
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.